nodes	percent_of_prediction	percent_of_DWPC	metapath
Procaterol—ADRB2—polycystic ovary syndrome	0.91	1	CbGaD
Procaterol—ADRB2—Adrenoceptors—ADRA1D—polycystic ovary syndrome	0.00762	0.0907	CbGpPWpGaD
Procaterol—ADRB2—Adrenoceptors—ADRA1B—polycystic ovary syndrome	0.00741	0.0882	CbGpPWpGaD
Procaterol—ADRB2—Adrenoceptors—ADRA1A—polycystic ovary syndrome	0.00562	0.0668	CbGpPWpGaD
Procaterol—ADRB2—Adrenoceptors—ADRB3—polycystic ovary syndrome	0.00541	0.0643	CbGpPWpGaD
Procaterol—Indacaterol—ADRB2—polycystic ovary syndrome	0.00396	0.644	CrCbGaD
Procaterol—ADRB2—Arf6 trafficking events—MAPK8IP3—polycystic ovary syndrome	0.00376	0.0447	CbGpPWpGaD
Procaterol—ADRB2—Arf6 signaling events—LHCGR—polycystic ovary syndrome	0.00283	0.0337	CbGpPWpGaD
Procaterol—ADRB2—Monoamine GPCRs—ADRA1D—polycystic ovary syndrome	0.0027	0.0321	CbGpPWpGaD
Procaterol—ADRB2—Monoamine GPCRs—ADRA1B—polycystic ovary syndrome	0.00262	0.0312	CbGpPWpGaD
Procaterol—ADRB2—Amine ligand-binding receptors—ADRA1D—polycystic ovary syndrome	0.00227	0.027	CbGpPWpGaD
Procaterol—ADRB2—Amine ligand-binding receptors—ADRA1B—polycystic ovary syndrome	0.0022	0.0262	CbGpPWpGaD
Procaterol—Isoetarine—ADRB2—polycystic ovary syndrome	0.00219	0.356	CrCbGaD
Procaterol—ADRB2—Monoamine GPCRs—ADRA1A—polycystic ovary syndrome	0.00199	0.0236	CbGpPWpGaD
Procaterol—ADRB2—Monoamine GPCRs—ADRB3—polycystic ovary syndrome	0.00191	0.0228	CbGpPWpGaD
Procaterol—ADRB2—Amine ligand-binding receptors—ADRA1A—polycystic ovary syndrome	0.00167	0.0199	CbGpPWpGaD
Procaterol—ADRB2—Amine ligand-binding receptors—ADRB3—polycystic ovary syndrome	0.00161	0.0191	CbGpPWpGaD
Procaterol—ADRB2—GPCRs, Other—ADRA1D—polycystic ovary syndrome	0.0012	0.0142	CbGpPWpGaD
Procaterol—ADRB2—G alpha (s) signalling events—LHCGR—polycystic ovary syndrome	0.00103	0.0122	CbGpPWpGaD
Procaterol—ADRB2—GPCRs, Other—FSHR—polycystic ovary syndrome	0.000965	0.0115	CbGpPWpGaD
Procaterol—ADRB2—Arf6 trafficking events—SLC2A4—polycystic ovary syndrome	0.00086	0.0102	CbGpPWpGaD
Procaterol—ADRB2—G alpha (s) signalling events—PDE3B—polycystic ovary syndrome	0.000827	0.00984	CbGpPWpGaD
Procaterol—ADRB2—Calcium Regulation in the Cardiac Cell—ADRA1D—polycystic ovary syndrome	0.000807	0.0096	CbGpPWpGaD
Procaterol—ADRB2—Calcium Regulation in the Cardiac Cell—ADRA1B—polycystic ovary syndrome	0.000785	0.00934	CbGpPWpGaD
Procaterol—ADRB2—G alpha (s) signalling events—FSHR—polycystic ovary syndrome	0.000753	0.00896	CbGpPWpGaD
Procaterol—ADRB2—G alpha (s) signalling events—ADRB3—polycystic ovary syndrome	0.000663	0.00789	CbGpPWpGaD
Procaterol—ADRB2—G alpha (s) signalling events—LHB—polycystic ovary syndrome	0.000655	0.0078	CbGpPWpGaD
Procaterol—ADRB2—G alpha (s) signalling events—SCT—polycystic ovary syndrome	0.000614	0.00731	CbGpPWpGaD
Procaterol—ADRB2—Calcium Regulation in the Cardiac Cell—ADRA1A—polycystic ovary syndrome	0.000595	0.00708	CbGpPWpGaD
Procaterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—NPB—polycystic ovary syndrome	0.000588	0.00699	CbGpPWpGaD
Procaterol—ADRB2—GPCRs, Class A Rhodopsin-like—PTGER3—polycystic ovary syndrome	0.000573	0.00681	CbGpPWpGaD
Procaterol—ADRB2—GPCRs, Class A Rhodopsin-like—LHCGR—polycystic ovary syndrome	0.000573	0.00681	CbGpPWpGaD
Procaterol—ADRB2—Calcium Regulation in the Cardiac Cell—ADRB3—polycystic ovary syndrome	0.000573	0.00681	CbGpPWpGaD
Procaterol—ADRB2—GPCRs, Class A Rhodopsin-like—PTAFR—polycystic ovary syndrome	0.000536	0.00637	CbGpPWpGaD
Procaterol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRA1D—polycystic ovary syndrome	0.00052	0.00619	CbGpPWpGaD
Procaterol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRA1B—polycystic ovary syndrome	0.000506	0.00602	CbGpPWpGaD
Procaterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—LHCGR—polycystic ovary syndrome	0.000491	0.00584	CbGpPWpGaD
Procaterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—PTGER3—polycystic ovary syndrome	0.000491	0.00584	CbGpPWpGaD
Procaterol—ADRB2—Arf6 trafficking events—INS—polycystic ovary syndrome	0.000483	0.00575	CbGpPWpGaD
Procaterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—PTAFR—polycystic ovary syndrome	0.000459	0.00546	CbGpPWpGaD
Procaterol—ADRB2—GPCR ligand binding—NPB—polycystic ovary syndrome	0.000448	0.00533	CbGpPWpGaD
Procaterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRA1D—polycystic ovary syndrome	0.000446	0.0053	CbGpPWpGaD
Procaterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRA1B—polycystic ovary syndrome	0.000433	0.00516	CbGpPWpGaD
Procaterol—ADRB2—GPCRs, Class A Rhodopsin-like—FSHR—polycystic ovary syndrome	0.000419	0.00499	CbGpPWpGaD
Procaterol—ADRB2—Calcium Regulation in the Cardiac Cell—CAMK2D—polycystic ovary syndrome	0.000412	0.00491	CbGpPWpGaD
Procaterol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRA1A—polycystic ovary syndrome	0.000383	0.00456	CbGpPWpGaD
Procaterol—ADRB2—GPCR ligand binding—PTGER3—polycystic ovary syndrome	0.000374	0.00445	CbGpPWpGaD
Procaterol—ADRB2—GPCR ligand binding—LHCGR—polycystic ovary syndrome	0.000374	0.00445	CbGpPWpGaD
Procaterol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRB3—polycystic ovary syndrome	0.000369	0.00439	CbGpPWpGaD
Procaterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—FSHR—polycystic ovary syndrome	0.000359	0.00427	CbGpPWpGaD
Procaterol—ADRB2—GPCR ligand binding—PTAFR—polycystic ovary syndrome	0.00035	0.00416	CbGpPWpGaD
Procaterol—ADRB2—GPCR ligand binding—ADRA1D—polycystic ovary syndrome	0.000339	0.00404	CbGpPWpGaD
Procaterol—ADRB2—G alpha (s) signalling events—GNAS—polycystic ovary syndrome	0.000332	0.00395	CbGpPWpGaD
Procaterol—ADRB2—GPCR ligand binding—ADRA1B—polycystic ovary syndrome	0.00033	0.00393	CbGpPWpGaD
Procaterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRA1A—polycystic ovary syndrome	0.000329	0.00391	CbGpPWpGaD
Procaterol—ADRB2—GPCRs, Class A Rhodopsin-like—MTNR1B—polycystic ovary syndrome	0.000326	0.00388	CbGpPWpGaD
Procaterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRB3—polycystic ovary syndrome	0.000316	0.00376	CbGpPWpGaD
Procaterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—LHB—polycystic ovary syndrome	0.000312	0.00372	CbGpPWpGaD
Procaterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—GNRH1—polycystic ovary syndrome	0.000305	0.00363	CbGpPWpGaD
Procaterol—ADRB2—Calcium Regulation in the Cardiac Cell—GNAS—polycystic ovary syndrome	0.000287	0.00341	CbGpPWpGaD
Procaterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—MTNR1B—polycystic ovary syndrome	0.000279	0.00332	CbGpPWpGaD
Procaterol—ADRB2—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.000274	0.00325	CbGpPWpGaD
Procaterol—ADRB2—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.000253	0.00301	CbGpPWpGaD
Procaterol—ADRB2—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.00025	0.00298	CbGpPWpGaD
Procaterol—ADRB2—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.000241	0.00286	CbGpPWpGaD
Procaterol—ADRB2—GPCR ligand binding—LHB—polycystic ovary syndrome	0.000238	0.00283	CbGpPWpGaD
Procaterol—ADRB2—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.000233	0.00277	CbGpPWpGaD
Procaterol—ADRB2—Signaling by GPCR—NPB—polycystic ovary syndrome	0.00023	0.00273	CbGpPWpGaD
Procaterol—ADRB2—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.000229	0.00272	CbGpPWpGaD
Procaterol—ADRB2—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.000224	0.00267	CbGpPWpGaD
Procaterol—ADRB2—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.000224	0.00267	CbGpPWpGaD
Procaterol—ADRB2—G alpha (s) signalling events—POMC—polycystic ovary syndrome	0.000224	0.00266	CbGpPWpGaD
Procaterol—ADRB2—GPCR ligand binding—SCT—polycystic ovary syndrome	0.000223	0.00265	CbGpPWpGaD
Procaterol—ADRB2—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.000213	0.00253	CbGpPWpGaD
Procaterol—ADRB2—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.000211	0.00251	CbGpPWpGaD
Procaterol—ADRB2—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.000211	0.00251	CbGpPWpGaD
Procaterol—ADRB2—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.000208	0.00247	CbGpPWpGaD
Procaterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.000206	0.00245	CbGpPWpGaD
Procaterol—ADRB2—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.000198	0.00235	CbGpPWpGaD
Procaterol—ADRB2—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.000192	0.00228	CbGpPWpGaD
Procaterol—ADRB2—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.000192	0.00228	CbGpPWpGaD
Procaterol—ADRB2—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.000192	0.00228	CbGpPWpGaD
Procaterol—ADRB2—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.000187	0.00222	CbGpPWpGaD
Procaterol—ADRB2—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.000179	0.00213	CbGpPWpGaD
Procaterol—ADRB2—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.000174	0.00207	CbGpPWpGaD
Procaterol—ADRB2—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.00017	0.00202	CbGpPWpGaD
Procaterol—ADRB2—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.000169	0.00202	CbGpPWpGaD
Procaterol—ADRB2—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.000157	0.00187	CbGpPWpGaD
Procaterol—ADRB2—Signaling Pathways—FLT4—polycystic ovary syndrome	0.000155	0.00185	CbGpPWpGaD
Procaterol—ADRB2—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.000155	0.00184	CbGpPWpGaD
Procaterol—ADRB2—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.000154	0.00183	CbGpPWpGaD
Procaterol—ADRB2—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.000141	0.00168	CbGpPWpGaD
Procaterol—ADRB2—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.00014	0.00167	CbGpPWpGaD
Procaterol—ADRB2—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.000136	0.00162	CbGpPWpGaD
Procaterol—ADRB2—Signaling Pathways—NPB—polycystic ovary syndrome	0.000136	0.00161	CbGpPWpGaD
Procaterol—ADRB2—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.000134	0.0016	CbGpPWpGaD
Procaterol—ADRB2—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.000131	0.00156	CbGpPWpGaD
Procaterol—ADRB2—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.000128	0.00153	CbGpPWpGaD
Procaterol—ADRB2—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.000126	0.0015	CbGpPWpGaD
Procaterol—ADRB2—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000124	0.00147	CbGpPWpGaD
Procaterol—ADRB2—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000123	0.00146	CbGpPWpGaD
Procaterol—ADRB2—Signaling by GPCR—LHB—polycystic ovary syndrome	0.000122	0.00145	CbGpPWpGaD
Procaterol—ADRB2—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000121	0.00143	CbGpPWpGaD
Procaterol—ADRB2—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.00012	0.00143	CbGpPWpGaD
Procaterol—ADRB2—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000119	0.00142	CbGpPWpGaD
Procaterol—ADRB2—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000114	0.00136	CbGpPWpGaD
Procaterol—ADRB2—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000113	0.00135	CbGpPWpGaD
Procaterol—ADRB2—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000113	0.00135	CbGpPWpGaD
Procaterol—ADRB2—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000109	0.0013	CbGpPWpGaD
Procaterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000107	0.00127	CbGpPWpGaD
Procaterol—ADRB2—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000106	0.00126	CbGpPWpGaD
Procaterol—ADRB2—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000103	0.00122	CbGpPWpGaD
Procaterol—ADRB2—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.0001	0.00119	CbGpPWpGaD
Procaterol—ADRB2—Signaling Pathways—INHBB—polycystic ovary syndrome	9.75e-05	0.00116	CbGpPWpGaD
Procaterol—ADRB2—Signaling Pathways—PDE3B—polycystic ovary syndrome	9.1e-05	0.00108	CbGpPWpGaD
Procaterol—ADRB2—GPCR downstream signaling—GHRL—polycystic ovary syndrome	8.88e-05	0.00106	CbGpPWpGaD
Procaterol—ADRB2—Signaling Pathways—FSHR—polycystic ovary syndrome	8.29e-05	0.000986	CbGpPWpGaD
Procaterol—ADRB2—GPCR ligand binding—POMC—polycystic ovary syndrome	8.12e-05	0.000966	CbGpPWpGaD
Procaterol—ADRB2—Signaling by GPCR—GHRL—polycystic ovary syndrome	8.06e-05	0.000959	CbGpPWpGaD
Procaterol—ADRB2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	7.8e-05	0.000927	CbGpPWpGaD
Procaterol—ADRB2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	7.58e-05	0.000902	CbGpPWpGaD
Procaterol—ADRB2—Signaling Pathways—FST—polycystic ovary syndrome	7.39e-05	0.000879	CbGpPWpGaD
Procaterol—ADRB2—Signaling Pathways—ADRB3—polycystic ovary syndrome	7.3e-05	0.000868	CbGpPWpGaD
Procaterol—ADRB2—Signaling Pathways—LHB—polycystic ovary syndrome	7.21e-05	0.000858	CbGpPWpGaD
Procaterol—ADRB2—Signaling Pathways—GNRH1—polycystic ovary syndrome	7.05e-05	0.000839	CbGpPWpGaD
Procaterol—ADRB2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	6.83e-05	0.000812	CbGpPWpGaD
Procaterol—ADRB2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	6.81e-05	0.000811	CbGpPWpGaD
Procaterol—ADRB2—Signaling Pathways—SCT—polycystic ovary syndrome	6.76e-05	0.000804	CbGpPWpGaD
Procaterol—ADRB2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	6.45e-05	0.000767	CbGpPWpGaD
Procaterol—ADRB2—Signaling Pathways—FGF18—polycystic ovary syndrome	6.34e-05	0.000754	CbGpPWpGaD
Procaterol—ADRB2—Signaling Pathways—RBP4—polycystic ovary syndrome	6.28e-05	0.000748	CbGpPWpGaD
Procaterol—ADRB2—Signaling by GPCR—GNAS—polycystic ovary syndrome	6.19e-05	0.000736	CbGpPWpGaD
Procaterol—ADRB2—Signaling Pathways—YAP1—polycystic ovary syndrome	5.87e-05	0.000698	CbGpPWpGaD
Procaterol—ADRB2—Signaling Pathways—GAB1—polycystic ovary syndrome	5.79e-05	0.000688	CbGpPWpGaD
Procaterol—ADRB2—Signaling Pathways—INSR—polycystic ovary syndrome	5.53e-05	0.000658	CbGpPWpGaD
Procaterol—ADRB2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	5.26e-05	0.000625	CbGpPWpGaD
Procaterol—ADRB2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	5.17e-05	0.000616	CbGpPWpGaD
Procaterol—ADRB2—Signaling Pathways—PGR—polycystic ovary syndrome	5.12e-05	0.000609	CbGpPWpGaD
Procaterol—ADRB2—Signaling Pathways—GHRL—polycystic ovary syndrome	4.76e-05	0.000567	CbGpPWpGaD
Procaterol—ADRB2—Signaling Pathways—PLAT—polycystic ovary syndrome	4.76e-05	0.000567	CbGpPWpGaD
Procaterol—ADRB2—GPCR downstream signaling—POMC—polycystic ovary syndrome	4.59e-05	0.000546	CbGpPWpGaD
Procaterol—ADRB2—Signaling Pathways—ATF1—polycystic ovary syndrome	4.54e-05	0.00054	CbGpPWpGaD
Procaterol—ADRB2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	4.43e-05	0.000527	CbGpPWpGaD
Procaterol—ADRB2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	4.41e-05	0.000525	CbGpPWpGaD
Procaterol—ADRB2—Signaling Pathways—NGFR—polycystic ovary syndrome	4.19e-05	0.000499	CbGpPWpGaD
Procaterol—ADRB2—Signaling by GPCR—POMC—polycystic ovary syndrome	4.17e-05	0.000496	CbGpPWpGaD
Procaterol—ADRB2—Signaling Pathways—PRL—polycystic ovary syndrome	4.16e-05	0.000494	CbGpPWpGaD
Procaterol—ADRB2—Signaling by GPCR—AKT2—polycystic ovary syndrome	4e-05	0.000476	CbGpPWpGaD
Procaterol—ADRB2—Signaling Pathways—GNAS—polycystic ovary syndrome	3.66e-05	0.000435	CbGpPWpGaD
Procaterol—ADRB2—Signaling Pathways—NCOR1—polycystic ovary syndrome	3.48e-05	0.000414	CbGpPWpGaD
Procaterol—ADRB2—Signaling Pathways—NRG1—polycystic ovary syndrome	3.42e-05	0.000407	CbGpPWpGaD
Procaterol—ADRB2—Signaling Pathways—IRS2—polycystic ovary syndrome	2.93e-05	0.000348	CbGpPWpGaD
Procaterol—ADRB2—Signaling Pathways—LEP—polycystic ovary syndrome	2.86e-05	0.000341	CbGpPWpGaD
Procaterol—ADRB2—Signaling Pathways—IRS1—polycystic ovary syndrome	2.56e-05	0.000304	CbGpPWpGaD
Procaterol—ADRB2—Signaling Pathways—POMC—polycystic ovary syndrome	2.46e-05	0.000293	CbGpPWpGaD
Procaterol—ADRB2—Signaling Pathways—INS—polycystic ovary syndrome	2.45e-05	0.000291	CbGpPWpGaD
Procaterol—ADRB2—Signaling Pathways—IGF1—polycystic ovary syndrome	2.37e-05	0.000282	CbGpPWpGaD
Procaterol—ADRB2—Signaling Pathways—AKT2—polycystic ovary syndrome	2.37e-05	0.000281	CbGpPWpGaD
Procaterol—ADRB2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.25e-05	0.000267	CbGpPWpGaD
Procaterol—ADRB2—Signaling by GPCR—IL6—polycystic ovary syndrome	1.81e-05	0.000215	CbGpPWpGaD
Procaterol—ADRB2—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.55e-05	0.000184	CbGpPWpGaD
Procaterol—ADRB2—Signaling Pathways—IL6—polycystic ovary syndrome	1.07e-05	0.000127	CbGpPWpGaD
